Acacia subsidiary obtains patent for stent graft technology

Acacia Research Corp (Nasdaq:ACTG) announced today that a subsidiary has acquired a patent for stent graft technology.    

"Acacia continues to increase the number of patent portfolios we control in the medical device and diagnostics sectors," commented Paul Ryan, CEO. "Acacia is expanding its presence as a leader in patent licensing for both the technology and medical technology sectors."



Posted in: Device / Technology News | Medical Patent News

Tags: ,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months